Tosatoxumab

Tax included
Tosatoxumab (AR-301; KBSA301) is a human immunoglobulin G1 monoclonal antibody that specifically neutralizes alpha-toxin (alpha-hemolysin; Hla) of S. aureus. Tosatoxumab binds to an N-terminal epitope of alpha-toxin, thereby preventing functional toxin pore oligomerisation. Tosatoxumab has the potential for passive immunotherapy in the S. aureus pneumonia as an adjunctive therapy to standard antibiotic agent.
MedChemExpress 
HY-P99551

Data sheet

Size
Multiple sizes
Reactivity
Antibiotic
Application
COVID-19-immunoregulation
CAS
1374419-41-6